Jeffrey P. Hodge
- Oncology top 2%
- Molecular Biology top 10%
- Pulmonary and Respiratory Medicine top 5%
- Immunology top 10%
- Cell Biology top 5%
- Co-authors
- Jia Xin YuVanessa M. Hubbard-LuceyJun TangSamik UpadhayaCristina OlivaA. Benjamin SuttleYunqing LinMohammed M. Dar
- Topics
- Microtubule and mitosis dynamics (11 papers)Cancer Treatment and Pharmacology (8 papers)Lung Cancer Treatments and Mutations (7 papers)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Jeffrey P. Hodge
38 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Oncology 1.3k
- Molecular Biology 794
- Pulmonary and Respiratory Medicine 566
- Immunology 400
- Cell Biology 252
Countries citing papers authored by Jeffrey P. Hodge
This map shows the geographic impact of Jeffrey P. Hodge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey P. Hodge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey P. Hodge more than expected).
Fields of papers citing papers by Jeffrey P. Hodge
This network shows the impact of papers produced by Jeffrey P. Hodge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey P. Hodge. The network helps show where Jeffrey P. Hodge may publish in the future.
Co-authorship network of co-authors of Jeffrey P. Hodge
This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey P. Hodge. A scholar is included among the top collaborators of Jeffrey P. Hodge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey P. Hodge. Jeffrey P. Hodge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Challenges and opportunities in the PD1/PDL1 inhibitor clinical trial landscapebreakdown → | 134 |
| 2 | 123 | |
| 3 | The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitorsbreakdown → | 301 |
| 4 | 2 | |
| 5 | 13 | |
| 6 | 1 | |
| 7 | 29 | |
| 8 | 85 | |
| 9 | 60 | |
| 10 | 72 | |
| 11 | 52 | |
| 12 | 171 | |
| 13 | 63 | |
| 14 | 12 | |
| 15 | 18 | |
| 16 | 8 | |
| 17 | Phase I study of ispinesib (SB-715992) in combination with docetaxel in patients with advanced solid tumors. | 1 |
| 18 | 129 | |
| 19 | 25 | |
| 20 | 52 |
About Jeffrey P. Hodge
Jeffrey P. Hodge is a scholar working on Oncology, Cell Biology and Cancer Research, having authored 39 papers that have together received 2.3k indexed citations. Recurring topics across this work include Microtubule and mitosis dynamics (11 papers), Cancer Treatment and Pharmacology (8 papers) and Lung Cancer Treatments and Mutations (7 papers). The work is most often cited by research in Oncology (1.3k citations), Reproductive Medicine (160 citations) and Immunology (400 citations). Jeffrey P. Hodge has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Jia Xin Yu, Vanessa M. Hubbard-Lucey, Jun Tang, Samik Upadhaya, Cristina Oliva, A. Benjamin Suttle, Yunqing Lin, Mohammed M. Dar, Lini Pandite and Joanne Lager. Their work appears in journals such as Journal of Clinical Oncology, Nature Reviews Drug Discovery and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.